Guofei Li
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Pharmacology top 10%
- Berberine and alkaloids research
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 10
- Cancer Treatment and Pharmacology 4
- Pharmacology 12
- Berberine and alkaloids research 6
- Plant-based Medicinal Research 4
- Co-authors
- Limei Zhao (20 shared papers)Mingming Zhao (14 shared papers)Feng Qiu (5 shared papers)Cuifang Cai (4 shared papers)Xing Tang (6 shared papers)Yu Zhang (3 shared papers)Mei Liu (2 shared papers)Futai Lu (3 shared papers)
- Journals
- International Journal of Pharmaceutics (7 papers)Drug Delivery (4 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Frontiers in Pharmacology (3 papers)Therapeutic Drug Monitoring (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Guofei Li
41 papers receiving 603 citations
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 95
- Pharmacology 74
- Biomaterials 110
- Molecular Medicine 31
- Analytical Chemistry 43
Countries citing papers authored by Guofei Li
This map shows the geographic impact of Guofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofei Li more than expected).
Fields of papers citing papers by Guofei Li
This network shows the impact of papers produced by Guofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofei Li. The network helps show where Guofei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guofei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 70 | |
| 2 | 2014 | 40 | |
| 3 | 2017 | 35 | |
| 4 | 2021 | 33 | |
| 5 | 2014 | 31 | |
| 6 | 2015 | 30 | |
| 7 | 2015 | 26 | |
| 8 | 2011 | 26 | |
| 9 | 2023 | 24 | |
| 10 | 2020 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2015 | 19 | |
| 14 | 2016 | 18 | |
| 15 | 2021 | 17 | |
| 16 | 2014 | 17 | |
| 17 | 2016 | 16 | |
| 18 | 2021 | 15 | |
| 19 | 2022 | 13 | |
| 20 | 2010 | 13 |
About Guofei Li
Guofei Li is a scholar working on Oncology, Pharmacology, Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 46 papers that have together received 627 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (6 papers), Cancer therapeutics and mechanisms (6 papers), Berberine and alkaloids research (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Drug Solubulity and Delivery Systems (5 papers), Cancer Treatment and Pharmacology (4 papers) and Plant-based Medicinal Research (4 papers). The work is most often cited by research in Pharmaceutical Science (95 citations), Pharmacology (74 citations), Biomaterials (110 citations), Molecular Medicine (31 citations) and Analytical Chemistry (43 citations). Guofei Li has collaborated with scholars based in China and United States. Frequent co-authors include Limei Zhao, Mingming Zhao, Feng Qiu, Cuifang Cai, Xing Tang, Xing Tang, Yu Zhang, Mei Liu, Futai Lu and Qiliang Deng. Their work appears in journals such as International Journal of Pharmaceutics, Drug Delivery, Journal of Pharmaceutical and Biomedical Analysis, Frontiers in Pharmacology and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.